Yang Zequan, Laubach Victor E, French Brent A, Kron Irving L
Department of Surgery, University of Virginia Health System, Charlottesville, VA 22908, USA.
J Thorac Cardiovasc Surg. 2009 Mar;137(3):723-9. doi: 10.1016/j.jtcvs.2008.08.056. Epub 2009 Jan 18.
Acute hyperglycemia is independently associated with larger myocardial infarct size in both diabetic and nondiabetic patients. We hypothesized that the oxidative stress imposed by acute hyperglycemia contributes to the exacerbation of infarct size during reperfusion.
C57BL/6 mice underwent 30 minutes of occlusion of the left anterior descending coronary artery followed by 60 minutes of reperfusion. Acute hyperglycemia was induced with an intraperitoneal injection of dextrose (2g/kg body weight) 30 minutes before left anterior descending occlusion. An antioxidant, N-2-mercaptopropionyl glycine, was injected intravenously 2 minutes before the onset of reperfusion at a dose of 20 mg/kg. A nicotinamide adenine dinucleotide phosphate oxidase inhibitor, apocynin (50 mg/kg), was applied either before or after the induction of hyperglycemia.
Blood glucose level before left anterior descending occlusion was 153 +/- 19 mg/dL in control mice and 444 +/- 26 mg/dL in hyperglycemic mice (P < .05). Plasma lipid peroxidation product (malondialdehyde) was significantly increased in both control and hyperglycemic mice at 1 hour after reperfusion, and levels of malondialdehyde in hyperglycemic mice were higher than that in control mice (3.38 +/- 0.21 vs 2.33 +/- 0.12 micromol/L; P < .05). N-2-mercaptopropionyl glycine administered just before reperfusion significantly reduced malondialdehyde levels in both control and hyperglycemic mice (1.21 +/- 0.06 and 1.03 +/- 0.24 micromol/L). Acute hyperglycemia increased infarct size (percent of risk region) from 34.0 +/- 2.7 to 49.4 +/- 1.6 (P < .05). N-2-mercaptopropionyl glycine reduced infarct size to 19.5 +/- 2.3 in control mice and to 26.2 +/- 2.9 in hyperglycemic mice. Apocynin also reduced malondialdehyde levels and infarct size in hyperglycemic mice if administered 5 minutes before injection of dextrose, but not before reperfusion.
Acute hyperglycemia enhances oxidative stress and exacerbates myocardial infarction in mice through activation of nicotinamide adenine dinucleotide phosphate oxidase.
急性高血糖与糖尿病和非糖尿病患者更大的心肌梗死面积独立相关。我们推测,急性高血糖所致的氧化应激会导致再灌注期间梗死面积扩大。
C57BL/6小鼠左冠状动脉前降支闭塞30分钟,随后再灌注60分钟。在左冠状动脉前降支闭塞前30分钟腹腔注射葡萄糖(2g/kg体重)诱导急性高血糖。在再灌注开始前2分钟静脉注射抗氧化剂N-2-巯基丙酰甘氨酸,剂量为20mg/kg。烟酰胺腺嘌呤二核苷酸磷酸氧化酶抑制剂阿朴吗啡(50mg/kg)在高血糖诱导之前或之后应用。
左冠状动脉前降支闭塞前,对照小鼠血糖水平为153±19mg/dL,高血糖小鼠为444±26mg/dL(P<.05)。再灌注1小时后,对照小鼠和高血糖小鼠血浆脂质过氧化产物(丙二醛)均显著增加,且高血糖小鼠丙二醛水平高于对照小鼠(3.38±0.21对2.33±0.12μmol/L;P<.05)。再灌注前给予N-2-巯基丙酰甘氨酸可显著降低对照小鼠和高血糖小鼠的丙二醛水平(1.21±0.06和1.03±0.24μmol/L)。急性高血糖使梗死面积(危险区域百分比)从34.0±2.7增加至49.4±1.6(P<.05)。N-2-巯基丙酰甘氨酸使对照小鼠梗死面积降至19.5±2.3,高血糖小鼠降至26.2±2.9。若在注射葡萄糖前5分钟给予阿朴吗啡,而非在再灌注前给予,则阿朴吗啡也可降低高血糖小鼠的丙二醛水平和梗死面积。
急性高血糖通过激活烟酰胺腺嘌呤二核苷酸磷酸氧化酶增强氧化应激并加重小鼠心肌梗死。